Advertisement

OB/GYN General

Screening for Gestational Diabetes in One Step Compared to Two Steps and Pregnancy Outcomes

Nov 11, 2022

For a study, researchers sought to compare one-step testing for gestational diabetes mellitus (GDM) to two-step testing to determine short-term maternal and newborn outcomes. Before September 2021,...

Infection Status & Survival Impact of hrHPV in CAC

Nov 01, 2022

Cervical adenocarcinoma (CAC) refers to various cancers that are not always linked to human papillomavirus (HPV). Similarly to what has been shown with cancers of other organs, it is becoming clear th...

Routine Informed Consent for MMR Testing in Endometrial Cancers

Nov 01, 2022

The purpose of this study was to synthesize current data with ethical principles to establish ethical best practices for obtaining informed consent for tumor testing for mismatch repair (MMR). Article...

A High Grade Serous Ovarian Cancer: Non-Genetic Mediators of Resistance to Platinum

Oct 31, 2022

The problem of cancer treatment resistance persists, and trustworthy preclinical models are limited. Using high-grade serous ovarian cancer (HGSC) as a case study, researchers investigated this unfulf...

Endosalpingiosis and Gynecologic Cancers

Oct 28, 2022

Endosalpingiosis is a disease characterized by ectopic epithelium that looks similar to the fallopian tubes. However, it is not well understood. It's been called a "malignancy-associated accidental pa...

Premenopausal Salpingo-oophorectomy and Clustering of Symptoms

Oct 28, 2022

Inadequate data makes it difficult to set realistic patient expectations after premenopausal risk-reducing salpingo-oophorectomy (RRSO). This study's objectives were to characterize post-RRSO symptom ...

Colposcopic Impression: Single Image Vs. 2-minute Time Series

Oct 27, 2022

For the purposes of education and telemedicine, colposcopic appearance is commonly categorized using still images, which conceal the dynamic nature of acetowhitening. In this study, researchers evalua...

Cell-free HPV DNA is a Promising Biomarker in Cervical Cancer

Oct 27, 2022

Cell-free tumor DNA (ctDNA), often known as a "liquid biopsy," is a tumor DNA sample released into the bloodstream by cancer cells. Here, researchers examined whether or not cell-free human papillomav...

Cardiovascular Disease Diagnoses Among Older EC Women

Oct 20, 2022

Even though endometrial cancer (EC) and cardiovascular disease (CVD) share risk factors (such as obesity), few studies have looked into the prevalence of CVD among EC survivors. Researchers set out to...

Early Cervical Cancer: Open Vs. Minimally Invasive RH

Oct 20, 2022

In early-stage cervical cancer in patients with usual-type adenocarcinoma and adenosquamous carcinoma, researchers aimed to evaluate the survival benefits of minimally invasive surgery (MIS) versus op...

OVA-LEAK: Colo-rectal Anastomotic Leakage Prognostic Score

Oct 19, 2022

The purpose of this research was to establish whether or not the OVA-LEAK score is superior to clinical criteria (surgeon's choice) for selecting anastomosis to be protected with a diverting ileostomy...

Unilateral Metastatic SN & Unilateral IFL in Early-stage VSCC Patients

Oct 19, 2022

Optimal therapy of the contralateral groin in individuals with early-stage vulvar squamous cell carcinoma (VSCC) with a metastatic unilateral inguinal sentinel lymph node (SN) is unknown. Researchers ...

Prophylactic Extended-field Irradiation for Locally Advanced Cervical Cancer

Oct 05, 2022

Concomitant chemoradiotherapy is the usual treatment for locally advanced cervical cancer. Pelvic irradiation is usually advised for patients with negative para-aortic lymph nodes (PALNs). However, ow...

Artificial Intelligence (AI) Use in Gynecologic Imaging

Oct 05, 2022

The phrases machine learning, deep learning, and artificial intelligence (AI) have entered practically every field of medicine. These approaches have advanced to the forefront of medical imaging resea...

Pembrolizumab Plus Lenvatinib as First-line Therapy for pMMR aEC

Oct 05, 2022

When compared to standard chemotherapy, the first-line combination of pembrolizumab plus lenvatinib (PL) for patients with mismatch repair-proficient (pMMR) advanced endometrial cancer (aEC) from the ...

MELF Pattern of Invasion: Molecular Features & Prognosis

Oct 05, 2022

Myometrial invasion with a microcystic, elongated, fragmented (MELF) pattern is a unique histologic characteristic rarely seen in low-grade endometrial carcinomas (EC). Due to contradictory results an...

Imaging with Molecular Profiling: Ovarian Cancer Resectability

Oct 05, 2022

In this study, researchers aimed to evaluate the prognostic utility of combining tumor molecular subtype with computerized tomography (CT) imaging for surgical outcomes following primary cytoreductive...

Distress in Half of Ovarian Cancer Patients

Oct 05, 2022

As part of cancer treatment, it is advised that patients be screened for and given support for distress. This study aimed to assess distress levels, potential triggers, and adherence to psychosocial f...

Cancer Demands and Navigating Job During Treatment

Oct 05, 2022

Researchers’ goal was to use the cancer-work management conceptual framework to solicit ovarian cancer patients' perspectives on job demands, cancer demands, and workplace or cancer services and tec...

Frozen Section Utility in Pediatric & Adolescent with Malignant Ovarian Tumors

Oct 05, 2022

Most ovarian cancers in women over 30 arise from preexisting epithelial cells. When deciding how extensive surgical staging is needed, it is helpful to employ an intraoperative frozen section to diffe...

SUBSPECIALTIES

Advertisement